Bcr-Abl inhibitors (Xi'an Jiaotong University)

N/A

Report date: 2025/03/18 18:11:26
NME

Base Information

Drug NameBcr-Abl inhibitors (Xi'an Jiaotong University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBcr-Abl tyrosine kinase inhibitors
TargetsBcr-Abl tyrosine kinase
Therapy Area/IndicationsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXi'An Jiaotong University
China Registration ClassN/A

Develop Information

Active CompaniesXi'An Jiaotong University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myelogenous, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A